Hologic, Inc. vs Johnson & Johnson — Stock Comparison

HOLX
Hologic, Inc.
$76.01
vs
JNJ
Johnson & Johnson
$227.19
▼ 1.16%
Q·Score Winner
Johnson & Johnson
JNJ7.1/10vs 6.1/10

Q·Score Breakdown

6.1
Neutral
Overall
7.1
Bullish
7
Quality
9.3
9.2
Health
6.5
4.4
Growth
5.1
6.5
Valuation
7.3
2.5
Sentiment
6.5
HOLX

Clean balance sheet with low leverage (0.5× debt-to-equity).

cautious analyst consensus — few Buy ratings.

JNJ

High-quality business with 26% return on equity and 22% profit margins.

earnings contracting 53% year-over-year.

Analyst Consensus

HOLD
Target $76.67 (+0.9%)
9 analysts
BUY
Target $252.42 (+11.1%)
24 analysts

Fundamentals

HOLX
JNJ
31.5×
Trailing P/E
26.3×
15.6×
Forward P/E
17.9×
13.2%
Profit Margin
21.8%
60.4%
Gross Margin
68.0%
10.9%
ROE
26.4%
2.5%
Revenue Growth
9.9%
-9.2%
Earnings Growth
-52.9%
0.70
Beta
0.33
Price / Book
$17.0B
Market Cap
$546.9B
$52 – $76
52-Week Range
$146 – $252

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →